Cannara Biotech, Inc. engages in the production of premium-grade cannabis and cannabis-derivative products. It operates under the Indoor Cannabis and Real Estate operating segments. The Indoor Cannabis segment is involved in cultivation, processing, and sale of dried cannabis and cannabis derivatives. The Real Estate segment focuses on the Farnham and Valleyfield building. The company was founded on October 19, 2017 and is headquartered in Montreal, Canada.
Sector:
Process Industries
Industry:
Agricultural Commodities Or Milling
Employees:
452
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Cannara Biotech Inc market cap is $138.3M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cannara Biotech Inc 52 week high is $1.66 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Cannara Biotech Inc 52 week low is $1.11 as of November 18, 2026.
Cannara Biotech Inc stock price today is $1.41.
Cannara Biotech Inc stock price yesterday was $1.40.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Cannara Biotech Inc's P/E ratio is 16.95.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Cannara Biotech Inc P/B ratio is 1.5138.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Cannara Biotech Inc 50-day moving average is $1.46.